-
2
-
-
0037968240
-
Gene transfer as a tool to induce therapeutic vascular growth
-
Yla-Herttuala S, Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat Med. 2003;9:694-701.
-
(2003)
Nat Med.
, vol.9
, pp. 694-701
-
-
Yla-Herttuala, S.1
Alitalo, K.2
-
3
-
-
0037714018
-
Vegf-d is the strongest angiogenic and lymphangiogenic effector among vegfs delivered into skeletal muscle via adenoviruses
-
Rissanen TT, Markkanen JE, Gruchala M, Heikura T, Puranen A, Kettunen MI et al. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res. 2003;92:1098-1106.
-
(2003)
Circ Res.
, vol.92
, pp. 1098-1106
-
-
Rissanen, T.T.1
Markkanen, J.E.2
Gruchala, M.3
Heikura, T.4
Puranen, A.5
Kettunen, M.I.6
-
4
-
-
33644877314
-
Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis
-
Rissanen TT, Korpisalo P, Markkanen JE, Liimatainen T, Orden MR, Kholova I et al. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis. Circulation. 2005;20;112: 3937-3946.
-
(2005)
Circulation
, vol.20
, Issue.112
, pp. 3937-3946
-
-
Rissanen, T.T.1
Korpisalo, P.2
Markkanen, J.E.3
Liimatainen, T.4
Orden, M.R.5
Kholova, I.6
-
5
-
-
17344371681
-
Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses
-
Puumalainen AM, Vapalahti M, Agrawal RS, Kossila M, Laukkanen J, Lehtolainen P et al. beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses. Hum Gene Ther. 1998;9:1769-1774.
-
(1998)
Hum Gene Ther.
, vol.9
, pp. 1769-1774
-
-
Puumalainen, A.M.1
Vapalahti, M.2
Agrawal, R.S.3
Kossila, M.4
Laukkanen, J.5
Lehtolainen, P.6
-
6
-
-
0030915715
-
Hcar and MCAR: The human and mouse cellular receptors for subgroup c adenoviruses and group b coxsackieviruses
-
Tomko RP, Xu R, Philipson L. HCAR and MCAR : The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A. 1997;94: 3352-3356.
-
(1997)
Proc Natl Acad Sci U S A
, vol.94
, pp. 3352-3356
-
-
Tomko, R.P.1
Xu, R.2
Philipson, L.3
-
7
-
-
0027166647
-
Integrins alpha V beta 3 and alpha V beta 5 promote adenovirus internalization but not virus attachment
-
Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell. 1993;73:309-319.
-
(1993)
Cell
, vol.73
, pp. 309-319
-
-
Wickham, T.J.1
Mathias, P.2
Cheresh, D.A.3
Nemerow, G.R.4
-
8
-
-
0034654569
-
Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions
-
Dechecchi MC, Tamanini A, Bonizzato A, Cabrini G. Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology. 2000;268:382-390.
-
(2000)
Virology
, vol.268
, pp. 382-390
-
-
Dechecchi, M.C.1
Tamanini, A.2
Bonizzato, A.3
Cabrini, G.4
-
9
-
-
0030994260
-
Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and b lymphoblastoid cells
-
Hong SS, Karayan L, Tournier J, Curiel DT, Boulanger PA. Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J. 1997;16:2294-2306.
-
(1997)
EMBO J.
, vol.16
, pp. 2294-2306
-
-
Hong, S.S.1
Karayan, L.2
Tournier, J.3
Curiel, D.T.4
Boulanger, P.A.5
-
10
-
-
0034739554
-
Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta
-
Hiltunen MO, Laitinen M, Turunen MP, Jeltsch M, Hartikainen J, Rissanen TT et al. Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation. 2000;102:2262-2268.
-
(2000)
Circulation
, vol.102
, pp. 2262-2268
-
-
Hiltunen, M.O.1
Laitinen, M.2
Turunen, M.P.3
Jeltsch, M.4
Hartikainen, J.5
Rissanen, T.T.6
-
11
-
-
21344445050
-
Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanism
-
Rutanen J, Turunen AM, Teittinen M, Rissanen TT, Heikura T, Koponen JK et al. Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanism. Gene Ther. 2005;12:980-987.
-
(2005)
Gene Ther.
, vol.12
, pp. 980-987
-
-
Rutanen, J.1
Turunen, A.M.2
Teittinen, M.3
Rissanen, T.T.4
Heikura, T.5
Koponen, J.K.6
-
12
-
-
12144291703
-
Oral imatinib mesylate (STI571/GLEEVEC) improves the efficacy of local intravascular vascular endothelial growth factor-c gene transfer in reducing neointimal growth in hypercholesterolemic rabbits
-
Leppanen O, Rutanen J, Hiltunen MO, Rissanen TT, Turunen MP, Sjoblom T et al. Oral imatinib mesylate (STI571/gleevec) improves the efficacy of local intravascular vascular endothelial growth factor-C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits. Circulation. 2004;109:1140-1146.
-
(2004)
Circulation
, vol.109
, pp. 1140-1146
-
-
Leppanen, O.1
Rutanen, J.2
Hiltunen, M.O.3
Rissanen, T.T.4
Turunen, M.P.5
Sjoblom, T.6
-
13
-
-
17344371184
-
Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia
-
Laitinen M, Mäkinen K, Manninen H, Matsi P, Kossila M, Agrawal RS et al. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum Gene Ther. 1998;9:1481-1486.
-
(1998)
Hum Gene Ther
, vol.9
, pp. 1481-1486
-
-
Laitinen, M.1
Mäkinen, K.2
Manninen, H.3
Matsi, P.4
Kossila, M.5
Agrawal, R.S.6
-
14
-
-
4644258829
-
Adenoviral vectors for gene transfer and therapy
-
Volpers C, Kochanek S. Adenoviral vectors for gene transfer and therapy. J Gene Med. 2004;6 Suppl 1:S164-S171.
-
(2004)
J Gene Med.
, vol.6
, pp. S164-S171
-
-
Volpers, C.1
Kochanek, S.2
-
15
-
-
0033541587
-
Expression of the primary coxsackie and adenovirus receptor is down regulated during skeletal muscle maturation and limits the efficacy of adenovirusmediated gene delivery to muscle cells
-
Nalbantoglu J, Pari G, Karpati G, Holland PC. Expression of the primary coxsackie and adenovirus receptor is down regulated during skeletal muscle maturation and limits the efficacy of adenovirusmediated gene delivery to muscle cells. Hum Gene Ther. 1999;10:1009-1019.
-
(1999)
Hum Gene Ther
, vol.10
, pp. 1009-1019
-
-
Nalbantoglu, J.1
Pari, G.2
Karpati, G.3
Holland, P.C.4
-
16
-
-
14044267666
-
Evaluation of angiogenesis and side effects in ischemic rabbit hindl imbs after intramuscular injection of adenoviral vectors encoding VEGF and Lacz
-
Vajanto I, Rissanen TT, Rutanen J, Hiltunen MO, Tuomisto TT, Arve K et al. Evaluation of angiogenesis and side effects in ischemic rabbit hindl imbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ. J Gene Med. 2002;4:371-380.
-
(2002)
J Gene Med.
, vol.4
, pp. 371-380
-
-
Vajanto, I.1
Rissanen, T.T.2
Rutanen, J.3
Hiltunen, M.O.4
Tuomisto, T.T.5
Arve, K.6
-
17
-
-
10744232374
-
Adenoviral catheter-mediated intra myocardial gene transfer using the mature form of vascular endothelial growth factor -d induces trans mural angiogenesis in porcine heart
-
Rutanen J, Rissanen TT, Markkanen JE, Gruchala M, Silvennoinen P, Kivela A et al. Adenoviral Catheter-Mediated Intramyocardial Gene Transfer Using the Mature Form of Vascular Endothelial Growth Factor -D Induces Trans mural Angiogenesis in Porcine Heart. Circulation. 2004;109: 1029-1035.
-
(2004)
Circulation
, vol.109
, pp. 1029-1035
-
-
Rutanen, J.1
Rissanen, T.T.2
Markkanen, J.E.3
Gruchala, M.4
Silvennoinen, P.5
Kivela, A.6
-
18
-
-
0032813580
-
Vascular permeability effect of adenovirus-mediated vascular endothelial growth factor gene transfer to the rabbit and rat skeletal muscle
-
Poliakova L, Kovesdi I, Wang X, Capogrossi MC, Talan M. Vascular permeability effect of adenovirus-mediated vascular endothelial growth factor gene transfer to the rabbit and rat skeletal muscle. J Thorac Cardiovasc Surg. 1999;118:339-347.
-
(1999)
J Thorac Cardiovasc Surg.
, vol.118
, pp. 339-347
-
-
Poliakova, L.1
Kovesdi, I.2
Wang, X.3
Capogrossi, M.C.4
Talan, M.5
-
19
-
-
32944459691
-
Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy
-
Thirion C, Lochmuller H, Ruzsics Z, Boelhauve M, Konig C, Thedieck C et al. Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy. Hum Gene Ther. 2006;17:193-205.
-
(2006)
Hum Gene Ther
, vol.17
, pp. 193-205
-
-
Thirion, C.1
Lochmuller, H.2
Ruzsics, Z.3
Boelhauve, M.4
Konig, C.5
Thedieck, C.6
-
20
-
-
22744434147
-
Localization of coxsackie virus and adenovirus receptor (CAR) in normal and regenerating human muscle
-
Sinnreich M, Shaw CA, Pari G, Nalbantoglu J, Holland PC, Karpati G. Localization of coxsackie virus and adenovirus receptor (CAR) in normal and regenerating human muscle. Neuromuscul Disord. 2005;15:541-548.
-
(2005)
Neuromuscul Disord.
, vol.15
, pp. 541-548
-
-
Sinnreich, M.1
Shaw, C.A.2
Pari, G.3
Nalbantoglu, J.4
Holland, P.C.5
Karpati, G.6
-
21
-
-
0038210219
-
Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: Phase ii results of the kuopio angiogenesis trial (KAT)
-
Hedman M, Hartikainen J, Syvanne M, Stjernvall J, Hedman A, Kivela A et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation. 2003;107: 2677-2683.
-
(2003)
Circulation
, vol.107
, pp. 2677-2683
-
-
Hedman, M.1
Hartikainen, J.2
Syvanne, M.3
Stjernvall, J.4
Hedman, A.5
Kivela, A.6
-
22
-
-
0036665610
-
Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: A randomized, placebo-controlled, double-blinded phase ii study
-
Makinen K, Manninen H, Hedman M, Matsi P, Mussalo H, Alhava E et al. Increased Vascularity Detected by Digital Subtraction Angiography after VEGF Gene Transfer to Human Lower Limb Artery: A Randomized, Placebo-Controlled, Double-Blinded Phase II Study. Mol Ther. 2002;6:127-133.
-
(2002)
Mol Ther
, vol.6
, pp. 127-133
-
-
Makinen, K.1
Manninen, H.2
Hedman, M.3
Matsi, P.4
Mussalo, H.5
Alhava, E.6
-
23
-
-
33747486473
-
Safety profile of plasmid/liposomes and virus vectors in clinical gene therapy
-
Wirth T, Hedman M, Mäkinen K, Manninen H, Immonen A, Vapalahti M et al. Safety Profile of Plasmid/Liposomes and Virus Vectors in Clinical Gene Therapy. Current Drug Safety. 2006;1: 253-257.
-
(2006)
Current Drug Safety
, vol.1
, pp. 253-257
-
-
Wirth, T.1
Hedman, M.2
Mäkinen, K.3
Manninen, H.4
Immonen, A.5
Vapalahti, M.6
-
24
-
-
0034022384
-
Effective repeat administration with adenovirus vectors to the muscle
-
Chen P, Kovesdi I, Bruder JT. Effective repeat administration with adenovirus vectors to the muscle. Gene Ther. 2000;7:587-595.
-
(2000)
Gene Ther
, vol.7
, pp. 587-595
-
-
Chen, P.1
Kovesdi, I.2
Bruder, J.T.3
-
25
-
-
27544513676
-
Gutless adenovirus: Last-generation adenovirus for gene therapy
-
S18-S27
-
Alba R, Bosch A, Chillon M. Gutless adenovirus: last-generation adenovirus for gene therapy. Gene Ther. 2005;12 Suppl 1:S18-S27.:S18-S27.
-
(2005)
Gene Ther
, Issue.12
, pp. S18-S27
-
-
Alba, R.1
Bosch, A.2
Chillon, M.3
-
26
-
-
0037090776
-
Conditional switching of vegf provides new insights into adult neovascularization and pro-angiogenic therapy
-
Dor Y, Djonov V, Abramovitch R, Itin A, Fishman GI, Carmeliet P et al. Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J. 2002;21:1939-1947.
-
(2002)
EMBO J.
, vol.21
, pp. 1939-1947
-
-
Dor, Y.1
Djonov, V.2
Abramovitch, R.3
Itin, A.4
Fishman, G.I.5
Carmeliet, P.6
-
27
-
-
0037689525
-
Induction of functional neo vascularization by combined VEGF and angiopoietin-1 gene transfer using aav vectors
-
Arsic N, Zentilin L, Zacchigna S, Santoro D, Stanta G, Salvi A et al. Induction of functional neo vascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Mol Ther. 2003;7:450-459.
-
(2003)
Mol Ther
, vol.7
, pp. 450-459
-
-
Arsic, N.1
Zentilin, L.2
Zacchigna, S.3
Santoro, D.4
Stanta, G.5
Salvi, A.6
-
28
-
-
33847421319
-
Vascular endothelial growth factors - biology and current status of clinical applications in cardiovascular medicine
-
Ref Type: In Press
-
Ylä-Herttuala, S., Rissanen, T., Vajanto, I., Hartikainen, J. Vascular endothelial growth factors - biology and current status of clinical applications in cardiovascular medicine. Journal of the American Cardiology of College. 2007. Ref Type: In Press.
-
(2007)
Journal of the American Cardiology of College
-
-
Ylä-Herttuala, S.1
Rissanen, T.2
Vajanto, I.3
Hartikainen, J.4
-
29
-
-
21244441929
-
Immune responses to adeno-associated virus vectors
-
Zaiss AK, Muruve DA. Immune responses to adeno-associated virus vectors. Curr Gene Ther. 2005;5:323-331.
-
(2005)
Curr Gene Ther.
, vol.5
, pp. 323-331
-
-
Zaiss, A.K.1
Muruve, D.A.2
-
30
-
-
23844487737
-
Lentiviral vectors and antiretroviral intrinsic immunity
-
Mangeat B, Trono D. Lentiviral vectors and antiretroviral intrinsic immunity. Hum Gene Ther. 2005;16:913-920.
-
(2005)
Hum Gene Ther
, vol.16
, pp. 913-920
-
-
Mangeat, B.1
Trono, D.2
-
31
-
-
0000410720
-
Catheter-mediated VEGF gene transfer to human lower limb arteries after PTA
-
2-11-1999
-
Mäkinen, K., Laitinen, M., Manninen, H., Matsi, P., Alhava, E., Ylä-Herttuala, S. Catheter-mediated VEGF gene transfer to human lower limb arteries after PTA. Circulation 100(18), 1-770. 2-11-1999.
-
Circulation
, vol.100
, Issue.18
, pp. 1-770
-
-
Mäkinen, K.1
Laitinen, M.2
Manninen, H.3
Matsi, P.4
Alhava, E.5
Ylä-Herttuala, S.6
-
32
-
-
0035859782
-
Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve
-
Rajagopalan S, Shah M, Luciano A, Crystal R, Nabel EG. Adenovirus-mediated gene transfer of vegf(121) improves lower-extremity endothelial function and flow reserve. Circulation. 2001;104:753-755.
-
(2001)
Circulation
, vol.104
, pp. 753-755
-
-
Rajagopalan, S.1
Shah, M.2
Luciano, A.3
Crystal, R.4
Nabel, E.G.5
-
33
-
-
0036710990
-
Phase i study of direct administration of a replication deficient adenovirus vector containing the vascular endothelial growth factor CDNA (ci-1023) to patients with claudication
-
Rajagopalan S, Trachtenberg J, Mohler E, Olin J, McBride S, Pak R et al. Phase I study of direct administration of a replication deficient adenovirus vector containing the vascular endothelial growth factor cDNA (CI-1023) to patients with claudication. Am J Cardiol. 2002;90:512-516.
-
(2002)
Am J Cardiol
, vol.90
, pp. 512-516
-
-
Rajagopalan, S.1
Trachtenberg, J.2
Mohler, E.3
Olin, J.4
Mcbride, S.5
Pak, R.6
-
34
-
-
0036147182
-
Analysis of risk factors for local delivery of low- And intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions
-
Crystal RG, Harvey BG, Wisnivesky JP, O'Donoghue KA, Chu KW, Maroni J et al. Analysis of risk factors for local delivery of low- And intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions. Hum Gene Ther. 2002;13:65-100.
-
(2002)
Hum Gene Ther
, vol.13
, pp. 65-100
-
-
Crystal, R.G.1
Harvey, B.G.2
Wisnivesky, J.P.3
O'Donoghue, K.A.4
Chu, K.W.5
Maroni, J.6
-
35
-
-
33748155036
-
Angiogenic gene therapy in patients with non revascularizable ischemic heart disease: A phase 2 randomized, controlled trial of advegf (121) (advegf121) versus maximum medical treatment
-
Stewart DJ, Hilton JD, Arnold JM, Gregoire J, Rivard A, Archer SL et al. Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease : A phase 2 randomized, controlled trial of AdVEGF (121) (AdVEGF121) versus maximum medical treatment. Gene Ther. 2006.
-
(2006)
Gene Ther
-
-
Stewart, D.J.1
Hilton, J.D.2
Arnold, J.M.3
Gregoire, J.4
Rivard, A.5
Archer, S.L.6
-
36
-
-
0142023866
-
Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: A phase ii randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent Claudication
-
Rajagopalan S, Mohler ER, III, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease : A phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation. 2003;108:1933-1938.
-
(2003)
Circulation
, vol.108
, pp. 1933-1938
-
-
Rajagopalan, S.1
Mohler, E.R.2
Lederman, R.J.3
Mendelsohn, F.O.4
Saucedo, J.F.5
Goldman, C.K.6
-
37
-
-
0037265253
-
Fibroblast growth factor-4 induces vascular permeability, angiogenesis, and arteriogenesis in a rabbit hind limb ischemia model
-
Rissanen TT, Markkanen JE, Arve K, Rutanen J, Kettunen MI, Vajanto I et al. Fibroblast growth factor-4 induces vascular permeability, angiogenesis, and arteriogenesis in a rabbit hind limb ischemia model. FASEB J. 2003;17:100-102.
-
(2003)
FASEB J.
, vol.17
, pp. 100-102
-
-
Rissanen, T.T.1
Markkanen, J.E.2
Arve, K.3
Rutanen, J.4
Kettunen, M.I.5
Vajanto, I.6
|